Amber M. Yates
Agios Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Myeloproliferative Neoplasms: Diagnosis and Treatment, Blood groups and transfusion, HIV/AIDS Research and Interventions
Most-Cited Works
- → Long-term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors(2021)147 cited
- → Fertility Preservation for Pediatric and Adolescent Patients With Cancer: Medical and Ethical Considerations(2020)94 cited
- → The diagnostic dilemma of congenital unstable hemoglobinopathies(2010)32 cited
- → Hydroxyurea treatment of children with hemoglobin SC disease(2012)31 cited
- → COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas(2021)22 cited
- → Evaluation for Bleeding Disorders in Suspected Child Abuse(2022)21 cited
- → Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial(2024)20 cited
- → Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report(2024)14 cited
- → Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates(2019)14 cited
- → Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial(2021)14 cited